Cellceutix is a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of small molecule drugs to treat conditions such as drug-resistant cancers and autoimmune diseases. The company’s flagship compound is an anti-cancer drug, Kevetrin. The company announced today that it is submitting an abstract for the upcoming 2013 American Socirty of Clinical Oncology [...]